EZZ Life Science Holdings Ltd (EZZ) - Total Liabilities

Latest as of December 2025: AU$4.80 Million AUD ≈ $3.39 Million USD

Based on the latest financial reports, EZZ Life Science Holdings Ltd (EZZ) has total liabilities worth AU$4.80 Million AUD (≈ $3.39 Million USD) as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Explore EZZ Life Science Holdings Ltd (EZZ) cash conversion ratio to assess how effectively this company generates cash.

EZZ Life Science Holdings Ltd - Total Liabilities Trend (2017–2024)

This chart illustrates how EZZ Life Science Holdings Ltd's total liabilities have evolved over time, based on quarterly financial data. Check EZZ Life Science Holdings Ltd liquidity resilience to evaluate the company's liquid asset resilience ratio.

EZZ Life Science Holdings Ltd Competitors by Total Liabilities

The table below lists competitors of EZZ Life Science Holdings Ltd ranked by their total liabilities.

Company	Country	Total Liabilities
Nucletron Electronic Aktiengesellschaft F:NUC	Germany	€2.08 Million
Northstar Clean Technologies Inc V:ROOF	Canada	CA$53.06 Million
Ikonisys SA PA:ALIKO	France	€7.50 Million
Ballymore Resources Ltd AU:BMR	Australia	AU$10.88 Million
Naas Technology Inc ADR NASDAQ:NAAS	USA	$1.26 Billion
Hammerson PLC LSE:HMSO	UK	GBX1.73 Billion
ERSU Meyve ve Gida Sanayi AS IS:ERSU	Turkey	TL95.95 Million
Konsortium Transnasional Bhd KLSE:4847	Malaysia	RM191.01 Million

Liability Composition Analysis (2017–2024)

This chart breaks down EZZ Life Science Holdings Ltd's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the full company profile including market capitalisation, see EZZ company net worth.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric	Value	Description
Current Ratio	6.57	Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio	N/A	More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio	N/A	Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity	0.17	Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets	0.15	Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how EZZ Life Science Holdings Ltd's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for EZZ Life Science Holdings Ltd (2017–2024)

The table below shows the annual total liabilities of EZZ Life Science Holdings Ltd from 2017 to 2024.

Year	Total Liabilities	Change
2024-12-31	AU$5.87 Million ≈ $4.15 Million	+38.83%
2023-12-31	AU$4.23 Million ≈ $2.99 Million	+38.28%
2022-12-31	AU$3.06 Million ≈ $2.16 Million	+6.27%
2021-12-31	AU$2.88 Million ≈ $2.04 Million	+49.05%
2020-12-31	AU$1.93 Million ≈ $1.37 Million	-48.86%
2019-12-31	AU$3.78 Million ≈ $2.67 Million	+80.61%
2018-12-31	AU$2.09 Million ≈ $1.48 Million	--
2017-12-31	AU$0.00 ≈ $0.00	--

About EZZ Life Science Holdings Ltd

AU:EZZ Australia Biotechnology

Market Cap

$21.30 Million

AU$30.11 Million AUD

Market Cap Rank

#24844 Global

#1077 in Australia

Share Price

AU$0.64

Change (1 day)

-9.22%

52-Week Range

AU$0.64 - AU$3.32

All Time High

AU$4.93